Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Anand Rathi recommends buying Apollo Hospitals and YES Bank, while Way2Wealth is positive on Allahabad Bank and Havells.
Saurabh Mittal of Swadeshi Credits advises buying Zee Entertainment with a target price of Rs 247 and Apollo Hospital with a target price of Rs 944.
Shardul Kulkarni, Angel Broking advised buying Dr Reddys Laboratories with a target of Rs 2520 and selling Unitech October Future with a stoploss at Rs 17.55.
Sudarshan Sukhani of s2analytics.com recommends buying Apollo Hospitals Enterprises in anticipation of beginning of a bounce. "The stock may bounce to Rs 1070," he adds.
Aashish Tater, Head of Research at Fortunewizard.com expect Apollo Hospitals to touch Rs 1400-1500 in next 18 months.
SP Tulsian of sptulsian.com advised buying Apollo Hospitals and JK Lakshmi Cement, and going short on Shree Renuka Sugars.
SP Tulsian of sptulsian.com says Apollo Hospitals Enterprises ruling close to around Rs 1000 looks a good buy because on Monday we have seen the late buying in the stock.
Aashish Tater, head of research at fortunewizard.com advised going short on Adani Power with a target price of Rs 50.5 and Arvind with a target price of Rs 81.
Apollo Hospitals is well placed and executed very well over the last few years, says UBS India's Gautam Chhaochharia. "This has shown in secular earnings growth in the past and has given investors a lot of confidence," he adds.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Apollo Hospitals Enterprises on dips. “After the up move Glenmark Pharma went into a small decline and that small decline was a technical flag, which is broken out of the upside and the up move should resume, â€he adds.
Saurabh Mittal of Swadeshi Capital is bullish on Siemens, Apollo Hospitals and MphasiS. However, he keeps sell rating on Divis Laboratories.
SP Tulsian of sptulsian.com advised buying JM Financial with a target price of Rs 28 and GSPL with a target price of Rs 61.
Saurabh Mittal of Swadeshi Capital is bullish on Apollo Hospitals Enterprises, Bharat Forge, Sintex Industries and Apollo Tyres.
SP Tulsian of sptulsian.com advised buying AstraZeneca Pharma with a target price of Rs 860 while Nooresh Merani of AMSEC Research recommended buying Dena Bank with a target price of Rs 92.
Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the stocks went up 20 percent in the last couple of months itself.
Apollo Hospitals has support around Rs 950, says SP Tulsian of sptulsian.com.
Sudarshan Sukhani of s2analytics.com advised selling partial holding in Apollo Hospitals. He feels the stock could continue hitting new lifetime highs.
On CNBC-TV18's Investor camp, SP Tulsian of sptulsian.com picked five stocks from the midcap space which should be on investor's radar till elections get announced (March or early 2014).
In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.
In CNBC-TV18's popular show Bull's Eye, Lancelot D Cunha, ITI Wealth Management shares trading strategy of the day.
In CNBC-TV18's popular show Bull's Eye, Saurabh Mittal, Swadeshi Credits shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Apollo Hospitals Enterprises is in the accumulation zone for last over couple of weeks or so and has been hovering at around Rs 800 and it is due to give a breakout which can make the stock move to about Rs 850 or so in next week to ten days, says SP Tulsian, sptulsian.com.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com says that he is optimistic on the market till mid-January due to heavyweight results like Tata Consultancy Services (TCS), Axis Bank, Wipro, Reliance Industries, HDFC Bank all lined up for the next couple of days.
SP Tulsian of sptulsian.com, says that after the change in management of OnMobile and considering the financials he is positive on the stock. He is also positive on select metal stocks.